Mattia Riondato
Overview
Explore the profile of Mattia Riondato including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
28
Citations
278
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Piccardo A, Fiz F, Righi S, Raffa S, Riondato M, Bottoni G, et al.
Eur Thyroid J
. 2025 Jan;
14(1).
PMID: 39792974
Background: In relapsing differentiated thyroid cancer (DTC), the in vivo evaluation of natrium-iodide symporter (NIS) expression is pivotal in the therapeutic planning and is achieved by 131/123Iodine (131/123I) whole body...
2.
Bauckneht M, DAmico F, Albano D, Balma M, Cabrini C, Dondi F, et al.
J Nucl Med
. 2024 Sep;
65(10):1577-1583.
PMID: 39237346
Unspecific bone uptake (UBU) related to [F]PSMA-1007 PET/CT imaging represents a clinical challenge. We aimed to assess whether a combination of clinical, biochemical, and imaging parameters could predict skeletal metastases...
3.
Carta S, Ghelardoni M, Vitale F, Ravera S, Cossu V, Bertola N, et al.
Front Biosci (Landmark Ed)
. 2024 Jul;
29(7):251.
PMID: 39082337
Background: Selective deprivation of glutamine has been shown to accelerate the generation of reactive oxygen species (ROS) and to impair the activity of a specific pentose phosphate pathway (PPP) located...
4.
Vitale F, Ghelardoni M, Chiesa S, Carta S, Losacco S, Orengo A, et al.
EJNMMI Res
. 2024 Jul;
14(1):64.
PMID: 38995321
No abstract available.
5.
Marini C, Cossu V, Lanfranchi F, Carta S, Vitale F, DAmico F, et al.
Cancers (Basel)
. 2023 Jul;
15(13).
PMID: 37444643
Background: Previous studies reported mitochondrial and endoplasmic reticulum redox stress in peripheral blood mononucleated cells (PBMCs) of treatment-naïve Hodgkin lymphoma (HL) patients. Here, we assessed whether this response also applies...
6.
Riondato M, Rigamonti D, Martini P, Cittanti C, Boschi A, Urso L, et al.
J Med Chem
. 2023 Apr;
66(7):4532-4547.
PMID: 37010457
Technetium-99m is the workhorse of diagnostic nuclear medicine. The aim of the work is to analyze the technetium-99m patents since 2000 to photograph its innovation. QUESTEL's ORBIT Intelligence system was...
7.
Bauckneht M, Miceli A, Signori A, Albano D, Capitanio S, Piva R, et al.
Eur Radiol
. 2023 Mar;
33(5):3343-3353.
PMID: 36892650
Objectives: Increased detection of prostate cancer (PCa) recurrences using [Ga]Ga-PSMA-11 PET/CT has been reported by adding forced diuresis or late-phase imaging to the standard protocol. However, the combination of these...
8.
Marini C, Cossu V, Carta S, Greotti E, Gaglio D, Bertola N, et al.
Antioxidants (Basel)
. 2023 Jan;
12(1).
PMID: 36670904
Cancer utilization of large glutamine equivalents contributes to diverging glucose-6-P flux toward the pentose phosphate shunt (PPP) to feed the building blocks and the antioxidant responses of rapidly proliferating cells....
9.
Lanfranchi F, Belgioia L, Marcenaro M, Zanardi E, Timon G, Riondato M, et al.
Cancers (Basel)
. 2023 Jan;
15(1).
PMID: 36612319
The superior diagnostic accuracy of [68Ga]Ga-prostate-specific membrane antigen-11 (PSMA) ([68Ga]Ga-PSMA-11) compared to [18F]F-Fluorocholine Positron Emission Tomography/Computed Tomography (PET/CT) in Prostate Cancer (PCa) is established. However, it is currently unclear if...
10.
Bauckneht M, Marini C, Cossu V, Campi C, Riondato M, Bruno S, et al.
J Transl Med
. 2023 Jan;
21(1):3.
PMID: 36600265
Background: Positron Emission Tomography (PET) imaging with Prostate-Specific Membrane Antigen (PSMA) and Fluorodeoxyglucose (FDG) represent promising biomarkers for risk-stratification of Prostate Cancer (PCa). We verified whether the expression of genes...